Biotage Invests in Biomolecules
Biotage AB has announced the purchase of shares in the Danish biomolecule company Chreto Aps, representing a significant investment into the area of drug development.
Biotage AB (Uppsala, Sweden) has announced the purchase of shares in the Danish biomolecule company Chreto Aps, representing a significant investment into the area of drug development.
Biomolecules are one of the fastest growing areas in drug development today, offering potential treatments to medical conditions poorly served by traditional pharmaceuticals.
“This investment makes an exciting part of our long-term strategic efforts,” explained Torben Jörgensen, CEO of Biotage. “We already have products for drug development based on peptides and are now taking one step further towards strengthening Biotage’s future offering in the biomolecule purification area.”
The deal, which sees Biotage own approximately 22% of Chreto, allows Biotage access to a wealth of biomolecule purification knowledge, as well as novel and patent protected technology.
For more information on Biotage please visit: www.biotage.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
